Designing a Multi-Epitope Vaccine Against HPV 16, 18, 33, and 45 Targeting L1 and E7 Proteins: An Immunoinformatics Approach for Cervical Cancer Prevention and Therapy
{{output}}
Cervical cancer, induced by human papillomavirus (HPV), ranks as the fourth most prevalent malignancy among women globally. Unfortunately, existing prophylactic vaccines lack therapeutic efficacy. This study aimed to design a multi-epitope vaccine targeting th... ...
